What makes blood stem cells transform? Regulation of RNA splicing may be an answer

Researchers at Lund University Faculty of Medicine have determined a novel mechanism linking the metabolism of ribonucleic acids, RNA, to the development of leukemia in myelodysplastic syndrome (MDS) patients. In a study published in the journal Molecular Cell, they explain what makes hematopoietic stem cells acquire malignant traits in cancer.